Disappearance and prevalence of extended-spectrum β-lactamase-producing Escherichia coli and other coliforms in the wastewater treatment process

Environ Sci Pollut Res Int. 2023 Jul;30(35):83950-83960. doi: 10.1007/s11356-023-28382-3. Epub 2023 Jun 23.

Abstract

Antibiotic-resistant bacteria (ARBs) can now be detected not only in clinical institutions but also in wastewater treatment plants (WWTPs), extending the range of emergence to residential areas. In this study, we investigated the change of antibiotic-resistant Escherichia coli (E. coli) and other coliforms in each treatment process at WWTPs. Throughout the treatment process, the numbers of E. coli and other coliforms were significantly reduced to less than 5.7 ± 0.5 CFU/100 ml and 2.4 ± 0.0×102 CFU/100 ml, respectively. However, ESBL-producing E. coli and other coliforms were detected in each treatment process (even after chlorination) at 5.6% and 4.8%, compared to the total E. coli and other coliforms counts. Then, ESBL-producing-related genes were identified via PCR analyses, and the most predominant gene was CTX-M-9 in both E. coli (47.2%) and other coliforms (47.3%). Although actual WWTPs greatly reduced the number of bacteria, the relative prevalence of ESBL-producing bacteria was increased, suggesting that ESBL-producing bacteria remain in the effluent at minimal concentrations and could be diffusing to water bodies.

Keywords: Municipal wastewater; ESBL-producing bacteria; ESBL-related genes; biological process; chlorination; survival.

MeSH terms

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Anti-Bacterial Agents / pharmacology
  • Escherichia coli* / genetics
  • Prevalence
  • Water Purification*
  • beta-Lactamases / genetics

Substances

  • Angiotensin Receptor Antagonists
  • beta-Lactamases
  • Angiotensin-Converting Enzyme Inhibitors
  • Anti-Bacterial Agents